The Journal of Clinical and Aesthetic Dermatology
Episodes
Ted Lain, MD: Long-Term Results of Deuruxolitinib for Alopecia Areata
17 Mar 2026
Contributed by Lukas
Send a textTed Lain, MD, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, shares his extensive experience with deuruxolitinib (...
James Del Rosso, DO: JCAD February 2026 Issue Highlights
26 Feb 2026
Contributed by Lukas
Send a textJames Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new resea...
Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata
19 Feb 2026
Contributed by Lukas
Send a textAmy McMichael, MD, a clinical professor and chair of the Department of Dermatology at Wake Forest School of Medicine, discusses deuruxoliti...
The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment
19 Feb 2026
Contributed by Lukas
Send a textJames Del Rosso, DO, and David Cotter, MD, PhD, discuss using gene expression profile testing, such as the AdvanceAD-Tx test, to provide ef...
Understanding Long-Term Treatment Success in Patient With Psoriasis
17 Feb 2026
Contributed by Lukas
Send a textGraham Litchman, DO, MS, a board-certified dermatologist at Vivida Dermatology in Las Vegas, Nevada, discusses a patient case involving a 5...
James Del Rosso, DO: JCAD January 2026 Issue Highlights
30 Jan 2026
Contributed by Lukas
Send us a textJames Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new re...
Aaron Farberg, MD: Real-World Experiences in Alopecia Areata Treatment
22 Jan 2026
Contributed by Lukas
Send us a textDr. Aaron Farberg, a board-certified dermatologist and founder of Bear Dermatology in Dallas, Texas, discusses the evolving treatment la...
Arash Mostaghimi, MD, MPH, FAAD: Considerations for the Use of Deuruxolitinib in Patients with Alopecia Areata
02 Dec 2025
Contributed by Lukas
Send us a textDr. Mostaghimi discusses the speed and and depth of efficacy of deuruxolitinib for providing hair regrowth in patients with severe alope...
James Del Rosso, DO: JCAD November 2025 Issue Highlights
20 Nov 2025
Contributed by Lukas
Send us a textDr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research pub...
Extended-cut Podcast—James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis
13 Nov 2025
Contributed by Lukas
Send us a textDrs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of ta...
James Del Rosso, DO: JCAD October 2025 Issue Highlights
30 Oct 2025
Contributed by Lukas
Send us a textDr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research pub...
David G. Cotter, MD, PhD: The Ideal Patient Candidate for Deuruxolitinib for Patients with Alopecia Areata
16 Oct 2025
Contributed by Lukas
Send us a textDr. Cotter discusses providing rapid hair regrowth in patients with alopecia areata.
David G. Cotter, MD, PhD: Utilizing the 31-gene Expression Profile Test in Patients with Melanoma
09 Oct 2025
Contributed by Lukas
Send us a textDr. Cotter discusses results of an expert consensus panel of the 31-gene expression profile test for patients with Melanoma.
James Del Rosso, DO: JCAD September 2025 Issue Highlights
24 Sep 2025
Contributed by Lukas
Send us a textDr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research pub...
David G. Cotter, MD, PhD: Providing Regrowth of Hair in Patients with Alopecia Areata
22 Sep 2025
Contributed by Lukas
Send us a textDr. Cotter discusses providing effective treatment for patients with alopecia areata
James Del Rosso, DO: JCAD August 2025 Issue Highlights
26 Aug 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
JCAD Dialogues and Reviews: Updates in Photoprotection and Recent Indication Expansions in Psoriasis and Rosacea
23 Jun 2025
Contributed by Lukas
Dr. Del Rosso discusses advancements in photoprotection formulations, as well as recent FDA approvals that have expanded treatment options for rosacea...
James Del Rosso, DO: JCAD June 2025 Issue Highlights
20 Jun 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
Extended-cut Podcast— Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis
27 May 2025
Contributed by Lukas
In this extended cut from JCAD’s recent Journal Review video series, Drs. Issa and Bunick dive into the possible mechanistic explanations behind art...
James Del Rosso, DO: JCAD May 2025 Issue Highlights
22 May 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
James Del Rosso, DO: JCAD April 2025 Issue Highlights
16 Apr 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
James Del Rosso, DO: JCAD February 2025 Issue Highlights
31 Jan 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
JCAD Dialogues and Reviews: Highlighting a Vitiligo Roundtable Discussion in JCAD
31 Jan 2025
Contributed by Lukas
Dr. James Del Rosso discusses a recent supplement that reviews insights about the challenges faced by both patients and clinicians in managing vitilig...
JCAD Dialogues and Reviews: Considerations for Antibiotic Adverse Events
28 Jan 2025
Contributed by Lukas
Dr. Del Rosso discusses potential adverse events that can occur when treating patients with trimethoprim-sulfamethoxazole.
James Del Rosso, DO: JCAD January 2025 Issue Highlights
03 Jan 2025
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
James Del Rosso, DO: Dermatology Year in Review 2024
17 Dec 2024
Contributed by Lukas
Dr. Del Rosso reviews some of the most impactful research developments and drug approvals seen by the dermatology world in 2024.
JCAD Dialogues and Reviews: Spotlight on a Newly Approved Treatment for Rosacea
21 Nov 2024
Contributed by Lukas
Dr. Del Rosso discusses warning signs of serious adverse events related to trimethoprim-sulfamethoxazole prescribed to patients with acne.
James Song, MD: Live from Elevate-Derm West—Why Older Immunosuppressant Agents are Still Relevant in 2024
11 Nov 2024
Contributed by Lukas
Dr. Song provides helpful clinical tips for treating patients with methotrexate.
James Song, MD: Live from Elevate-Derm West—New Topical and Systemic Agents for Atopic Dermatitis
11 Nov 2024
Contributed by Lukas
Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.
James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab
18 Oct 2024
Contributed by Lukas
Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.
James Del Rosso, DO: JCAD October 2024 Issue Highlights
18 Oct 2024
Contributed by Lukas
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the ...
Leon Kircik, MD: Recent IL-17 Inhibitor Approval for Patients with Psoriasis
14 Nov 2023
Contributed by Lukas
Dr. Kircik discusses a recent FDA-approval of an IL-17 inhibitor that has demonstrated to be safe and effective in patients with psoriasis.
James Del Rosso, DO: Diagnostic Pearls for Psoriasis
17 Oct 2023
Contributed by Lukas
Dr. Del Rosso discusses how to provide the correct treatment for the various presentations of psoriasis along with the impact psoriatic arthritis can ...
Joel Gelfand, MD, MSCE, FAAD: Managing Cardiovascular Risk in Patients with Psoriasis
21 Sep 2023
Contributed by Lukas
Dr. Gelfand discusses how to treat patients with psoriasis in terms of cardiovascular risk. He encourages clinicians to educate their patients about t...
James Del Rosso, DO: Consulting Patients with Psoriasis on Biologic Therapy
09 Aug 2023
Contributed by Lukas
Dr. Del Rosso discusses ways in which he’s modified his consultation style when speaking to patients with psoriasis who are about to commence treatm...
George Martin, MD: The Utilization of TNF Inhibitors for Psoriasis
11 Jul 2023
Contributed by Lukas
George Martin, MD, discusses the specific role TNF inhibitors play for the treatment of psoriasis along with an important safety implication to be awa...
James Del Rosso, DO: Identifying Appropriate Patients for TNF inhibitors
23 Jun 2023
Contributed by Lukas
Dr. Del Rosso discusses biologic options for treating patients with psoriasis and psoriatic arthritis as well as pregnant patients.
Linda Stein Gold, MD: Updates in Systemic Therapies for Psoriasis
09 May 2023
Contributed by Lukas
Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab.
George Martin, MD: The Current Role of TNF Inhibitors for Psoriasis
25 Apr 2023
Contributed by Lukas
George Martin, MD, discusses TNF inhibitors for the treatment of psoriasis and how these classic biologic agents currently fit into the ever-expanding...
Raj Chovatiya, MD, PhD: Mechanisms of Atopic Dermatitis Therapies
22 Feb 2023
Contributed by Lukas
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medi...
Nicole Keeter, MSHS, PA-C: Incorporating Topical and Oral Treatments into Your Practice
21 Nov 2022
Contributed by Lukas
Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alop...
Nicole Keeter, MSHS, PA-C: Focusing on Safety Consideration for the Prescription of JAK Inhibitors
27 Oct 2022
Contributed by Lukas
After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-...
James Del Rosso, DO: Topical Treatment for Atopic Dermatitis
20 Sep 2022
Contributed by Lukas
Dr. James Del Rosso reviews various common treatments for atopic dermatitis, specifically topical agents that have demonstrated effectiveness for pati...
Peter Lio, MD: The Evolution of Topical JAK Inhibitors
25 Aug 2022
Contributed by Lukas
Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the de...
James Del Rosso, DO: The Benefits of Topical JAK Inhibitors
09 Aug 2022
Contributed by Lukas
Dr. James Del Rosso discusses the benefits of topical JAK inhibitors over oral JAK inhibitors for the treatment of atopic dermatitis.
Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors
23 Jun 2022
Contributed by Lukas
Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus k...
Lisa Swanson, MD: Counseling Patients on JAK Inhibitors
03 May 2022
Contributed by Lukas
Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, discusses how she intends to ...
Doris Day, MD: The Effect of Stress on Hair Health
19 Apr 2022
Contributed by Lukas
Raj Chovatiya, MD, PhD: Discussing Atopic Dermatitis Treatment Risks with Patients
08 Mar 2022
Contributed by Lukas
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medi...
Douglas DiRuggiero, DMSc, PA-C: Safety of JAK Inhibitors for Atopic Dermatitis
21 Dec 2021
Contributed by Lukas
Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis.
Matt Zirwas, MD: Patient Preparatory Guidance for Topical JAK Inhibitors
21 Dec 2021
Contributed by Lukas
Matthew Zirwas, MD, provides guidance on speaking with patients with atopic dermatitis about treating their condition with topical JAK inhibitors.
Douglas DiRuggiero, DMSc, PA-C: An Overview of JAK Inhibitors for Atopic Dermatitis
01 Dec 2021
Contributed by Lukas
Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic derm...
Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis
01 Dec 2021
Contributed by Lukas
Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis...